RLIG1
RNA ligase 1
Also known as: C12orf29, DKFZp434N2030, RLIG1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N999
- Gene
- RLIG1
- Ensembl
- ENSG00000133641
- Chromosome
- 12
- Canonical length
- 325 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Enables RNA ligase (ATP) activity. Involved in response to reactive oxygen species. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
325 residues, UniProt reviewed canonical sequence.
>Q8N999|RLIG1
1 MKRLGSVQRK MPCVFVTEVK EEPSSKREHQ PFKVLATETV SHKALDADIY SAIPTEKVDG
61 TCCYVTTYKD QPYLWARLDR KPNKQAEKRF KNFLHSKENP KEFFWNVEED FKPAPECWIP
121 AKETEQINGN PVPDENGHIP GWVPVEKNNK QYCWHSSVVN YEFEIALVLK HHPDDSGLLE
181 ISAVPLSDLL EQTLELIGTN INGNPYGLGS KKHPLHLLIP HGAFQIRNLP SLKHNDLVSW
241 FEDCKEGKIE GIVWHCSDGC LIKVHRHHLG LCWPIPDTYM NSRPVIINMN LNKCDSAFDI
301 KCLFNHFLKI DNQKFVRLKD IIFDVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RLIG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 15 nTPM
- skin: 15 nTPM
- epididymis: 12 nTPM
- liver: 12 nTPM
- breast: 10 nTPM
- cerebral cortex: 9.4 nTPM
Single-cell type
- esophageal apical cells: 460 nCPM
- oocytes: 157 nCPM
- esophageal suprabasal cells: 120 nCPM
- suprabasal keratinocytes: 79 nCPM
- late primary spermatocytes: 54 nCPM
- early spermatids: 53 nCPM
Immune cell
- MAIT T-cell: 4.9 nTPM
- naive CD4 T-cell: 4.6 nTPM
- basophil: 4.5 nTPM
- memory CD4 T-cell: 3.9 nTPM
- naive CD8 T-cell: 3.9 nTPM
- NK-cell: 3.4 nTPM
Brain region
- cerebral cortex: 9.6 nTPM
- white matter: 9.6 nTPM
- basal ganglia: 8 nTPM
- midbrain: 8 nTPM
- hypothalamus: 7.9 nTPM
- spinal cord: 7.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.36
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- RNA ligase (ATP) activity
Protein domainsUniProt · Pfam · InterPro
- RNA ligase 1
- RNA ligase 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RLIG1 as an antibody target. Whether an autoantibody or antibody against RLIG1 could matter depends on whether native RLIG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RLIG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RLIG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...